Trial NCT06046482

View at ClinicalTrials.gov 
Org. Study IDs: 2022-0903
Secondary IDs: NCI-2023-07199

Last trial update was posted on 2024-04-12

MeSH Interventions

Cetuximab Docetaxel Magrolimab Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Squamous Cell Carcinoma of Head and Neck

Other Conditions

Head Neck

Stopping Reasons

PI Request

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID